» Articles » PMID: 31173610

Upregulation of Sphingosine-1-phosphate Receptor 3 on Fibroblast-like Synoviocytes is Associated with the Development of Collagen-induced Arthritis Via Increased Interleukin-6 Production

Overview
Journal PLoS One
Date 2019 Jun 8
PMID 31173610
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sphingosine-1-phosphate receptor 3 (S1P3) is one of five receptors for sphingosine-1-phosphate (S1P). S1P/S1P3 signaling is involved in numerous physiological and pathological processes including bone metabolism, sepsis, cancer, and immunity. In rheumatoid arthritis (RA), fibroblast-like synoviocytes (FLSs) are activated by several factors and promote abundant proinflammatory cytokine production and bone destruction. The aim of this study was to investigate whether S1P3 is associated with the development of autoimmune arthritis and the pathogenic function of FLSs.

Methods: Wild-type (WT) and S1P3 knockout (S1P3-KO) collagen-induced arthritis (CIA) mice were evaluated with respect to clinical and histological disease severity, along with the levels of anti-collagen antibodies and expression of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6). S1P3 expression in the synovium was analyzed by real-time reverse-transcription polymerase chain reaction (RT-PCR) and immunofluorescence staining. FLSs isolated from CIA mice were activated with TNFα and S1P3 expression was analyzed by real-time RT-PCR. The role of S1P/S1P3 signaling in activated and non-activated FLSs was investigated by measuring cell proliferation and cyto/chemokine production by real-time RT-PCR and/or enzyme-linked immunosorbent assay.

Results: Clinical and histological scores, and synovial IL-6 expression were significantly lower in S1P3-KO mice with CIA than in WT mice. Arthritic synovia had higher S1P3 expression than intact synovia and FLSs in arthritic joints expressed S1P3 in vivo. Primary cultured FLSs produced IL-6 in a time-dependent manner in response to S1P stimulation and exhibited higher levels of S1P3 expression after activation with TNFα. S1P3-induced production of IL-6 and MMP-3 was increased in FLSs pre-activated with TNFα.

Conclusion: In this study, we demonstrated that S1P3 expression is associated with the development of autoimmune arthritis via inflammation-induced increases in S1P/S1P3 signaling that increase production of IL-6 in FLSs. Inhibition of S1P/S1P3 signaling could open the door to the development of new therapies for RA.

Citing Articles

Blocking the Sphingosine-1-Phosphate Receptor 2 (S1P) Reduces the Severity of Collagen-Induced Arthritis in DBA-1J Mice.

Lee J, Lee J, Im D Int J Mol Sci. 2025; 25(24.

PMID: 39769163 PMC: 11677552. DOI: 10.3390/ijms252413393.


Broad and diverse roles of sphingosine-1-phosphate/sphingosine-1-phosphate receptors in the prostate.

Liu D, Liu J, Li Y, Du L, Cao Q, Yang L iScience. 2024; 27(12):111290.

PMID: 39618500 PMC: 11607605. DOI: 10.1016/j.isci.2024.111290.


Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis.

Kumar A, Tatarian J, Shakhnovich V, Chevalier R, Sudman M, Lovell D Metabolites. 2024; 14(9).

PMID: 39330506 PMC: 11434325. DOI: 10.3390/metabo14090499.


S1P/S1PR signaling pathway advancements in autoimmune diseases.

Li J, Huang Y, Zhang Y, Liu P, Liu M, Zhang M Biomol Biomed. 2023; 23(6):922-935.

PMID: 37504219 PMC: 10655875. DOI: 10.17305/bb.2023.9082.


Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment.

Alexandropoulou I, Grammatikopoulou M, Gkouskou K, Pritsa A, Vassilakou T, Rigopoulou E Nutrients. 2023; 15(1).

PMID: 36615886 PMC: 9824311. DOI: 10.3390/nu15010229.


References
1.
Zhao C, Amiable N, Laflamme M, Marsolais D, Di Battista J, Fernandes M . Impairment of chemical hypoxia-induced sphingosine kinase-1 expression and activation in rheumatoid arthritis synovial fibroblasts: A signature of exhaustion?. Biochem Pharmacol. 2019; 165:249-262. DOI: 10.1016/j.bcp.2019.02.009. View

2.
Smolen J, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E . Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008; 371(9617):987-97. DOI: 10.1016/S0140-6736(08)60453-5. View

3.
Murakami K, Kohno M, Kadoya M, Nagahara H, Fujii W, Seno T . Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model. PLoS One. 2014; 9(9):e106792. PMC: 4157792. DOI: 10.1371/journal.pone.0106792. View

4.
Smolen J, Aletaha D, Barton A, Burmester G, Emery P, Firestein G . Rheumatoid arthritis. Nat Rev Dis Primers. 2018; 4:18001. DOI: 10.1038/nrdp.2018.1. View

5.
Wooley P, Whalen J, Chapdelaine J . Collagen-induced arthritis in mice. VI. Synovial cells from collagen arthritic mice activate autologous lymphocytes in vitro. Cell Immunol. 1989; 124(2):227-38. DOI: 10.1016/0008-8749(89)90127-5. View